SEC Filings

SEC Filings

Filing date	Description	Form	Company	View
Apr 02, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-022728.pdf 0001209191-19-022728.rtf View HTML
Apr 01, 2019	Initial filing by director officer or owner of more than ten percent.	3	Surface Oncology	0001209191-19-021978.pdf 0001209191-19-021978.rtf View HTML
Mar 07, 2019	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-19-006767.pdf 0001564590-19-006767.rtf 0001564590-19-006767.xls View HTML
Mar 07, 2019	Securities offered to employees pursuant to employee benefit plans	S-8	Surface Oncology	0001193125-19-067260.pdf 0001193125-19-067260.rtf 0001193125-19-067260.xls View HTML
Mar 07, 2019	Annual report which provides a comprehensive overview of the company for the past year	10-K	Surface Oncology	0001564590-19-006783.pdf 0001564590-19-006783.rtf 0001564590-19-006783.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Mar 04, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-015868.pdf 0001209191-19-015868.rtf View HTML
Mar 04, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-015877.pdf 0001209191-19-015877.rtf View HTML
Mar 04, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-015870.pdf 0001209191-19-015870.rtf View HTML
Mar 04, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-015872.pdf 0001209191-19-015872.rtf View HTML
Mar 04, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-015891.pdf 0001209191-19-015891.rtf View HTML

Copyright Morningstar